Skip to content

Effect of perioperative dexmedetomidine on long-term prognosis of patients with renal cell carcinoma after operation

Effect of perioperative dexmedetomidine on long-term prognosis of patients with renal cell carcinoma after operation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120291
Enrollment
Unknown
Registered
2026-03-11
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Interventions

Control group:None

Sponsors

Guangxi Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.To undergo radical nephrectomy or partial nephrectomy ( including open or minimally invasive surgery ) under general anesthesia in the Affiliated Tumor Hospital of Guangxi Medical University from January 2015 to December 2025; 3.Postoperative pathological diagnosis of renal cell carcinoma ( all subtypes included ); 4.Have complete and traceable electronic anesthesia records, surgical records, pathological reports and inpatient medical records;

Exclusion criteria

Exclusion criteria: 1.Concurrent or previous history of other malignant tumors; 2.Patients with severe heart, lung, liver and kidney dysfunction ( such as ASA grade >= IV ), or with severe mental illness or dementia who cannot cooperate with follow-up; 3.Patients with severely missing medical records and unable to obtain key variables ( such as anesthetic medication details, follow-up survival status );

Design outcomes

Primary

MeasureTime frame
Postoperative progression-free survival;

Secondary

MeasureTime frame
Postoperative ICU stay time;The incidence of major complications;Postoperative hospital stay;Postoperative tumor reexamination / metastasis;

Countries

China

Contacts

Public ContactDongqin Huang

Guangxi Medical University Cancer Hospital

13978871245@163.com+86 771 5324383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026